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Renal phosphate excretion in spontaneously hypertensive and normo-
tensive Wistar Kyoto rats. Renal tubular reabsorption of phosphate was
studied in unanesthetized spontaneously hypertensive (SHR) and nor-
motensive Wistar Kyoto rats (WKY). Three-hour-urinary phosphate
excretions of 12-week-old-male SHR (53.0 13.1 sgImg creatinine, N
= 7) and 14-week-old female SHR (81.8 12.8, N = 8) were
significantly lower than those of age sex-matched WKY (12 week, 435.8
73.2, N = 8,P <0.01; 14 week, 423.3 75.9, N = 8,P <0.01). Renal
clearances were performed in 14-week-old female rats after an over-
night fast. The serum phosphate concentration of SHR (4.61 0.25
mg/dl) was lower than that of WKY (5.44 0.14, P < 0.02). Urinary
phosphate excretion (UV = 6.85 1.83 tg/min) and fractional
phosphate excretion (FEe, = 13.7 2.3%) of SHR were lower than
those of WKY (UV = 15.9 1.87 gImin, P < 0.01, FE, 22.8
2.6%,P < 0.02). Acute hyperventilation could not account for the lower
excretion of phosphate in SHR, since arterial pH and Pco2 were not
different between WKY and SHR. The low renal phosphate clearance
of SHR was noted at a very early age; the U,V of 5-week-old SHR was
already lower than that of WKY. Maximum tubular phosphate reab-
sorption (TmPi) was studied in the 12-week-old SHR and WKY after
acute thyroparathyroidectomy. TmPi of SHR (241 3.0g/ml GFRI100
g, N = 7) was greater than that of WKY (204 7.0, N = 8, P < 0.01).
However, the differences in 3-hr urinary phosphate excretion and
clearances of phosphate were abolished between SHR and WKY after
their blood pressures were lowered by chronic hydralazine treatment.
The results indicate that hypertension is responsible for the lower renal
phosphate clearances in SHR.
Excretion rénale de phosphates chez des rats Wistar Kyoto spontané-
ment hypertendus et normotendus. La reabsorption tubulaire des phos-
phates a été étudiée chez des rats Wistar Kyoto (WKY) éveillés,
spontanément hypertendus (SHR) et normotendus. Les excretions
urinaires de phosphates de 3 heures chez des SHR males de 12 semaines
(53,0 13,1 /Lg/mg créatinine, N = 7) et des femelles SHR de 14
semaines (8 1,8 12,8, N = 8) étaient significativement plus faibles que
celles chez des WKY d'âge et de sexe identiques (12 semaines, 435,8
73,2, N = 8, P <0,01; 14 semaines, 423,3 75,9, N = 8, P <0,01). Des
clearances rénales ont été faites chez des rats femelles de 14 semaines
apres une nuit de jeQne. La concentration sérique de phosphates des
SHR (4,61 0,25 mg/dl) était plus faible que celle des WKY (5,44
0,14, P < 0,02). L'excrétion urinaire de phosphates (UV = 6,85 1,83
sg/min) et l'excrétion fractionnelle de phosphates (FE = 13,7 2,3%)
des SHR étaient plus faibles que celles des WKY (UV 15,9 1,87
g/min, P < 0,01, FE1 22,8 2,6%, P < 0,02). Une hyperventilation
aiguë ne pouvait expliquer Ia plus faible excretion de phosphates chez
les SHR puisque le pH et Ia Pco2 artériels ne différaient pas entre WKY
et SHR. La faible clearance rénale des phosphates des SHR était notée
a un age trés jeune; UV des SHR de 5 semaines était déjà plus faible
que celle des WKY. La reabsorption maximale tubulaire des phos-
phates (TmPi) a été étudiée chez des SHR et des WKY de 12 semaines
apres thyro-parathyroIdectomie aigue. TmPi des SHR (241 3,0LgIml
GFR/100 g, N = 7)était plus élevée que celle des WKY (204 7,0, N =
8, P < 0,01). Cependant, les differences d'excrétion urinaire des
phosphates de 3 heures et de clearance de phosphates étaient abolies
entre SHR et WKY aprés que leur pression artérielle ait été abaissée
par un traitement chronique avec de l'hydralazine. Ces résultats
indiquent que l'hypertension est responsable des plus faibles clearances
rénales des phosphates chez les SHR.
Recent studies indicate that calcium metabolism is abnormal
in spontaneously hypertensive rats (SHR). The derangements
of calcium metabolism include hypercalciuria [1], low serum
ionized calcium concentration [1—3], and elevated serum para-
thyroid hormone (PTH) levels [1, 4, 51. Abnormal phosphate
metabolism has been implicated by low serum phosphate levels
in SHR [6, 7]. Low serum phosphate concentration has also
been reported in human hypertensive subjects [8, 9]. Further-
more, serum phosphate concentrations are inversely related to
blood pressure (BP) values in normotensive subjects [10], and
the serum phosphate concentration is significantly lower in
hyperparathyroidism associated with hypertension than it is in
hyperparathyroidism associated with normotensive BP levels
[11].
This is a study of phosphate metabolism in SHR and normo-
tensive Wistar Kyoto rats (WKY). Results indicate that phos-
phate clearance is lower in SHR than in WKY. Maximum
tubular reabsorption of phosphate is significantly greater in
SHR following acute thyroparathyroidectomy (TPTX). The
abnormal phosphate excretion is abolished following chronic
reduction of BP with hydralazine.
Methods
Studies were performed on WKY and SHR obtained from
Charles River Breeding Laboratories, Wilmington, Massachu-
setts. Three WKY and three SHR were housed together in a
cage. All rats were fed with rat chow (Ralston Purina, St. Louis,
Missouri) and water ad libitum for 1 week before the experi-
ments. Measurements of 3-hr urinary excretions of phosphate,
sodium, and creatinine were initially conducted in 12-week-old
male WKY and SHR (weighing 230 to 260 g) and 14-week-old
female WKY and SHR (weighing 170 to 200 g) before studying
the renal clearance of phosphate. Animals were not fasted
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overnight. They were placed in individual metabolic cages
without food or water during the 3-hr urine collection period.
All urine samples were collected from 9 A.M. to noon.
Two days following the completion of initial measurements of
phosphate excretion, the 14-week-old female WKY and SHR
underwent clearance studies of sodium, calcium, phosphate,
and magnesium. In addition, 5-week-old female WKY and SHR
also underwent identical clearance studies. For the clearance
studies rats were fasted overnight, but allowed free access to
water prior to the experiments. On the day of study, rats were
weighed and anesthetized with ether. Both femoral artery and
vein were cannulated with polyethylene tubing (PE10) for blood
collection, BP measurement, and infusion. Mean arterial pres-
sure (MAP) was monitored using a recorder (Gilson, Medical
Co., Middleton, Wisconsin) and transducer (model P23Db,
Gould Statham Instruments Inc., Hato Rey, Puerto Rico). APE
50 tubing was inserted into the bladder for urine collection.
Following surgery the rats were placed in restraining cages, and
clearance studies were carried out without anesthesia.
Glomerular filtration rate (GFR) was estimated by the clear-
ance of sodium '251-iodothalamate. A priming dose of 1251
iodothalamate in normal saline, I ml/lOO g body weight, was
infused over 15 mm, followed by a sustaining infusion at a rate
of 0.0 125 ml/min/l00 g. Clearance studies were started after 40
mm of sustaining infusion in each animal. Heparinized blood
(0.8 ml) was obtained at the middle of a 40-mm urine collection.
At the end of the clearance period, arterial blood was immedi-
ately withdrawn in 14-week-old animals for blood pH, P02,
Pco2, and 2,3-diphosphoglyceric acid (2,3-DPG) measure-
ments. Animals were quickly killed by an overdose of
pentobarbital.
Tubular reabsorption of phosphate (TRPi) was studied in 12-
week-old male WKY and SHR. Animals were fasted overnight
but had free access to drinking water. On the day of the
experiment all rats underwent acute TPTX and cauterization of
the gland under ether anesthesia, Femoral arterial and venous
catheters were inserted as previously described. The bladder
was also catheterized for urine collection. Animals were then
placed in restraining cages, and TRPi was conducted with them
in an awake condition. TRPi studies were begun 2 hr after
TPTX [12, 13]. Starting at 1 hr after TPTX, a priming dose of
125j iodothalamate in normal saline, 1 ml/l00 g body weight was
infused in 10 mm, followed by a sustaining infusion of saline
containing 125! iodothalamate for 50 mm before the clearance
studies at a rate of 0.0125 ml/min/lOO g. After a 30-mm urine
collection was obtained, during which time normal saline was
infused at 0.0125 ml/min/100 g throughout the clearance, the
saline solution was replaced with phosphate and 125j iodothala-
mate containing solutions. Phosphate solutions were 20, 40, and
80 m, all with a sodium concentration of 150 m. The
solutions were adjusted to pH 7.40. The infusion was kept
constant at a rate of 0.0125 ml/min/lOO g throughout the
experiments. The phosphate was delivered at progressively
increasing rates of 0.25, 0.50 and 1.0 tmoles/min/I00 g. Infusion
of each phosphate solution proceeded for 15 mm before a 30-
mm clearance was started. At the midpoint of each clearance, a
0.4 ml blood sample was obtained.
Phosphate excretion was further studied in 12-week-old male
SHR and WKY after they were treated with hydralazine.
Animals were fed with rat chow (Ralston Purina). In addition,
Table 1. Values of 3-hr urinary phosphate and sodium excretions in
Wistar Kyoto normotensive (WKY) and hypertensive (SHR) ratsa
Age Sex
Weight
g
IjNa'%1
pEqlmg Cr
U1V
gImg Cr
12WkWKY M 242 161.3 435.8
(N = 8) 14.0
12 Wk SHR M 252 169.7 53.0
(N = 7) 13.1
P value NS NS <0.01
14WkWKY F 187 139.0 423.3
(N = 8) 10.0
14 Wk SHR F 188 220.9 81.8
(N = 8)
P value NS NS <0.01
Abbreviations: F, female; M, male; UNaV, urinary sodium excretion;
U1V, urinary phosphate excretion; Cr, creatinine.
a Values are mean SEM; statistical analyses were done by Student's
test.
both SHR and WKY (10 weeks of age) received hydralazine,
125 mg/liter, in their drinking water for 14 days before we
studied phosphate excretions. The systolic BP was determined
weekly with the animals unanesthetized using a sphygmoma-
nometer with pneumatic pulse transducer and tail cuff (Grass
Polygraph, Quincy, Massachusetts). Three-hour urinary excre-
tions of phosphate, sodium, and creatinine were measured in
each animal without overnight fast. Food and hydralazine were
not given during the 3-hr urine collection. Average MAP was
increased less than 12 mm Hg after 200 mm without hydralazine
in both WKY and SHR (unpublished observation). Renal
clearances of phosphate and sodium were performed in animals
after overnight fast but with free access to drinking water
containing hydralazine. The experimental procedures were
identical to those of 14-week-old female SHR and WKY. BP
was monitored and hydralazine was not given during the
experiment.
1251 radioactivity was counted in a gamma counter (Packard
Instruments, United Technology, Downers Grove, Illinois).
Sodium concentration was measured by flame photometer.
Phosphate was determined by the method of Chen, Toribara,
and Warner [14]. Calcium and magnesium were measured by
atomic absorption spectrophotometer (model 306, Perkin
Elmer, Norwalk, Connecticut). Urinary creatinine was mea-
sured by the method of Bonsnes and Taussky [15]. Blood pH,
P02, and Pco2 determinations were performed with a blood gas
analyzer (model 813, Instrumentation Lab, Lexington, Massa-
chusetts) on samples obtained at the end of the clearance
period. Blood 2,3-DPG was measured as described previously
[16].
All values are expressed as mean SEM. Statistical compari-
sons are made with Student's or paired t tests where
appropriate.
Results
Three-hour urinary phosphate excretions of both male and
female 12 and 14-week-old WKY were significantly greater than
the respective values of age-sex-matched SHR animals (Table
1). WKY and SHR animals excreted equal amounts of sodium
and their body weights were not different.
Renal clearances of phosphate, calcium, magnesium, and
sodium were studied in 14-week-old WKY and SHR (Table 2).
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Table 2. Renal clearances of phosphate, calcium, magnesium and sodium in female Wistar Kyoto normotensive (WKY) and hypertensive
(SHR) ratsa
Age
Weight
g
Ht
%
MAP
mm Hg
GFR
nilIminIlOO g mgldl
PCa
mg/dI
PMg
mgldl
UnV
/j.g/min
FED,
%
UcaV
g/min
UMSV
gImin
FENa
%
5-week-old WKY 47 41.6 94 0.70 7.05 8.45 2.06 5.78 28.3 0.10 0.70 0.38(N = 8) ±2.0 ±1.0 ±4.3 ±0.10 ±0.36 ±0.39 ±0.08 ±0.58 ±4.2 ±0.02 ±0.36 ±0.14
5-week-old SHR 58.4 41.2 108 0.73 6.38 8.97 2.18 4.00 16.7 0.20 0.88 0.77(N = 8) ±3.2 ±0.9 ±1.9 ±0.08 ±0.26 ±0.18 ±0.05 ±0.36 ±3.0 ±0.04 ±0.15 ±0.22
P value <0.01 NS <0.01 NS NS NS NS <0.02 <0.05 0.06 NS NS
14-week-old WKY 179 39.8 120 0.72 5.44 8.50 2.22 15.90 22.8 0.52 2.59 0.46(N = 8) ±2.7 ±0.9 ±1.9 ±0.01 ±0.14 ±0.32 ±0.10 ±1.87 ±2.6 ±0.08 ±0.41 ±0.08
14-week-old SHR 172 41.6 139 0.69 4.61 10.07 2.22 6.85 13.7 0.49 2.62 0.38(N = 8) ±2.8 ±0.9 ±3.4 ±0.05 ±0.25 ±0.39 ±0.11 ±1.83 ±2.3 ±0.09 ±0.58 ±0.06
P value NS NS <0.01 NS <0.02 <0.01 NS <0.01 <0.02 NS NS NS
Abbreviations: Ht, hematocrit; MAP, mean arterial pressure; P, plasma phosphate concentration; PCa, plasma calcium concentration; PMg,
plasma magnesium concentration; FE1, fractional phosphate excretion; UcaV, urinary calcium excretion; UMgV, urinary magnesium excretion,
FENa, fractional sodium excretion.
a Values are mean ± SEM; statistical analyses were done by Student's t test.
MAP was significantly higher in SHR than in WKY. GFR was
not different between the two groups of rats. Plasma phosphate
concentration of SHR was lower than that of WKY, and total
plasma calcium concentration of SHR was higher than that of
WKY. Plasma magnesium concentration was not different
between WKY and SHR. Both urinary phosphate and fractional
phosphate excretions were significantly greater in WKY than in
SHR, but urinary calcium and magnesium excretions, as well as
fractional sodium excretion, were not different.
To determine the earliest age in which the decreased phos-
phate excretion of SHR may occur, similar clearance studies
were conducted in 5-week-old rats (Table 2). MAP was already
higher in SHR than in WKY, and body weight of SHR was
heavier than that of WKY. GFR and plasma concentrations of
phosphate, calcium, and magnesium were not different between
the two groups of rats. WKY and SHR excreted equal amounts
of calcium and magnesium; however, urinary phosphate and
fractional phosphate excretions of WKY were already slightly,
but significantly, greater than those of SHR.
The influence of respiration on phosphate excretion was
examined in 14-week-old WKY and SHR. Values of blood
gases and pH were not different between WKY and SHR (Table
3). Furthermore, 2,3-DPG content of red blood cells was also
not different in the two groups of rats (Table 3).
The results of TRPi following phosphate infusion in acute
TPTX in 12-week-old male SHR and WKY are presented in
Table 4. TPTX was verified by demonstrating the changes in
plasma phosphate concentration before and after TPTX. Plas-
ma phosphate concentrations of WKY (7.51 ± 0.34 mg/dl, N =
8) and SHR (6.81 ± 0.29 mg/dl, N = 7) prior to TPTX were
significantly lower than those values of WKY (8.30 ± 0.20, N =
8, P < 0.01) and SHR (7.96 ± 0.24, N = 7, P < 0.01),
respectively, obtained during the first period of clearance after
TPTX. MAP was higher in SHR than in WKY after TPTX.
There were no differences in GFR and plasma sodium concen-
trations in each clearance period between WKY and SHR.
Plasma phosphate concentrations rose, and plasma calcium
concentrations declined progressively, during a stepwise in-
crease in phosphate infusion in both WKY and SHR. By the
third and fourth clearance periods, plasma concentration of
phosphate was higher and plasma concentration of calcium was
Table 3. Values of blood gases and 2,3-DPG of 14-week-old female
WKY and SHRa
pH
units
Pco2
mm Hg
P02
mm Hg
2,3-DPG
jsM/g Hb
WKY 7.46 35.4 96.1 23.9"
(N = 7) ±0.01 ±1.6 ±2.8 ±3.8
SHR 7.46 33.5 96.9 22.9"
(N = 8)
P values
±0.01
N5
±1.1
NS
±2.8
NS
±1.7
NS
Abbreviation: Hb, hemoglobin.
a Values are mean ± SEM.
b This value represents the average values of five animals.
lower in SHR. A filtered load of phosphate was not different
between WKY and SHR during phosphate infusion. Renal
phosphate excretion tended to be lower in SHR; therefore,
TRPi was greater in SHR during the progressively increasing
rates of phosphate infusion. However, urinary sodium excre-
tion and fractional sodium excretion were significantly greater
in SHR than in WKY during the first two clearance periods,
whereas they were not different during the third and fourth
clearance periods. The urinary phosphate excretion at any
given urinary sodium excretion rate was higher in WKY than in
SHR. There was a linear correlation between phosphate excre-
tion and sodium excretion in WKY (Up,V = 11.4 + 15.9 X
UNaV, r = 0.87, P < 0.01), whereas, such correlation was not
found in SHR (Fig. 1),
Figure 2 presents the values of maximum tubular reabsorp-
tion of phosphate (TmPi) of each WKY and SHR. Mean value
of TmPi of SHR (241 ± 3.0 g/ml GRF/100 g, N = 7) was
significantly greater than that of WKY (204 ± 7.0 tg/ml
GRF/l00 g, N = 8, P < 0.01). Most of the TmPi of SHR were
achieved at higher concentrations of plasma phosphate than
those of WKY.
With chronic hydralazine treatment systolic BP was signifi-
cantly reduced by day 6 from 158 ± 3.4 to 124 ± 5.2 mm Hg in
SHR (P <0.01) and remained suppressed throughout the period
of treatment. BP was higher in SHR before hydralazine, but it
was not different between WKY (122 ± 3.6) and SHR (121 ± 3.2
mm Hg) by tail cuff measurement at the end of the 2-week
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Table 4. Tabular reabsorption of phosphate following phosphate infusion in acute thyroparathyroidectomy ratsa
Amount of TRP1/
Pj infused x GFR GFR
Clearance p.M/mini MAP Ht GFR PNa UNaV FENaV Ppj PCa p.g/min/ FE1 p.gIml/
period 100 g mm Hg % mlIminIlOO g mEqiliter p.Eqlmin % mg/dl mgidl 100 g % 100 g
WKY (N = 8)
1 0 119 44.8 0.70 139 0.19 0.08 8.30 7.96 57.6
2 0.25 0.72 140 0.63 0.26 9.13 7.79 65.4 9.2 200
3 0.50 0.78 141 1.59 0.58 9.85 7.50 76.5 21.2 191
4 1.0 0.83 141 2.41 0.83 10.5 6.74 86.9 29.4 179
SHR (N = 7)
1 0 155 45.6 0.78 140 2.05' 0.76d 7,96 7.96 62.0 2.Ib 196
2 0.25 0.79 141 2.85d 1.Old 9.49 7.43 75.2 5.6 225C
3 0.50 0.77 141 2.42 0.87 10.6" 6.91C 80.9
4 1.0 0.78 141 3.04 1.08 ll.7d 6.21c 90.8 21.4 231"
Abbreviations: Pi, phosphate; PNa, plasma sodium concentration; TRPi, tubular reabsorption of phosphate. Other abbreviations are the same as
those used in Tables 1 and 2.
Values are mean 5EM.
b D < 0.05, P < 0.03, d P < 0.01, using Student's t test comparing WKY and SHR for each pair of clearance periods.
revealed that MAP of WKY was slightly, but significantly,
lower than that of SHR after hydralazine therapy. Urinary
phosphate excretion and fractional phosphate excretion were,
however, not different between WKY and SHR, while fraction-
al sodium excretion was significantly higher in SHR than in
WKY. GFR and plasma phosphate concentrations were not
different between the two groups of animals.
Discussion
A recent study [6] demonstrates that SHR exhibits signifi-
cantly lower serum phosphate concentrations than either WKY
or Sprague-Dawley rats. The lower serum phosphate concen-
tration in SHR is noted from newborn to 3 months of age.
Others also have found lower serum phosphate levels in SHR
between 11 to 17 weeks of age [7]. We, however, have not
found a consistently lower serum phosphate concentration in
SHR. The present observations demonstrate that the renal
clearance of phosphate was decreased and TmPi was increased
in SHR. The reduced renal phosphate clearance was detected at
a very early age; the urinary phosphate excretion of 5-week-old
SHR was already lower than that of WKY. Consequently, the
lower serum concentration of phosphate in SHR cannot be
attributed to renal loss of phosphate.
Although the rats in the present studies were not totally
immobilized, they were placed in restraining cages during the
clearance studies. This partial immobilization of rats might
cause excitement and hyperventilation in animals, perhaps
somewhat more so in SFIR. Acute hyperventilation is known to
reduce renal phosphate excretion [17]. This, however, could
not account for the decreased renal phosphate clearance, since
the results of blood gases indicate that arterial pH and Pco2
were not different between WKY and SHR.
It is also possible that the lower serum phosphate concentra-
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Fig. 1. Relatiunship between sodium excretion and phosphate excretion
in WKY(O)andSHR(S).
treatment. Weight gain was comparable in both groups of rats.
Average values of 3-hr urinary phosphate and sodium excre-
tions after chronic hydralazine administration were not different
between WKY and SHR (Table 5). Renal sodium and phos-
phate clearances were subsequently studied in these groups of
rats (Table 6). Although mean values of systolic BP were not
different between WKY and SHR using the tail cuff method,
direct monitoring of BP through the femoral arterial catheter
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Age Sex
Weight
g
UNaV
p.Eqlmg Cr
UV
gImg Cr
12-week WKY M 246 217.1 224.6
(N = 9)
12-week SHR M 242 269.5 170.0
(N = 9)
P value NS NS NS
rats may eventually stimulate renal preservation of phosphate
even in the presence of elevated circulating PTH. Phosphate
depletion, however, was not detected in SHR in the present
study, since the determination of 2,3-DPG content of RBC was
not different between WKY and SHR. This parameter may not
be sensitive enough to disclose mild phosphate depletion in
rats.
The reason for the higher PTH concentration in SHR and
hypertensive subjects is unknown. It has been proposed that
hypercalciuria due to hypertension may be pathogenetically
— related to this endocrinological disorder [8, 10]. This hypothesis
13 is tenuous, however, since PTH is increased in 10-week-old
SHR before they develop hypercalciuria [5]. Alternatively the
mechanism of "hyperparathyroidism" in SHR may involve
depressed intestinal calcium absorption and abnormal vitamin
D metabolism [23]. Serum concentrations of l,25-dihydroxy-
cholecalciferol and 24,25-dihydroxycholecalciferol are not dif-
ferent between WKY and SHR, whereas the serum concentra-
tion of 25-hydroxycholecalciferol is significantly higher in SHR.
The decreased calcium absorption in the presence of normal
1 ,25-dihydroxycholecalciferol levels suggests unresponsiveness
of the intestine to vitamin D. Intestinal absorption of calcium in
SHR is controversial as other investigators have found that
calcium absorption by the duodenum is actually increased [24].
The latter study, however, also demonstrated that intestinal
calcium absorption is relatively unresponsive to vitamin D
administration in SHR but not in WKY. Whether or not
intestinal phosphate absorption is suppressed in SHR has not
been investigated.
Other metabolic alterations in SHR include decreased 24-hr
urinary excretion of cyclic AMP as well as generation of cyclic
AMP [7, 25]. The decreased formation of cyclic AMP by the
kidney in the presence of an elevated PTH concentration
indicates renal unresponsiveness to PTH stimulation. Howev-
er, if decreased cyclic AMP generation is primarily responsible
for the decreased phosphate excretion, hyperphosphatemia
rather than hypophosphatemia should be a prevalent manifesta-
tion in SHR.
If phosphate depletion accounts for the decreased renal
phosphate excretion, there are two possible etiologies to con-
sider: (1) Renal loss. Since phosphate excretion is already
decreased in 5-week-old SHR, renal wasting of phosphate must
occur at an earlier age. (2) Decreased intestinal absorption.
Phosphate absorption consists of two processes: One is a
saturable, carrier-mediated transport, the other is a linear
concentration-dependent passive diffusion [26]. However, in-
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Table 5. Values of 3-hr urinary phosphate and sodium excretions in
Wistar Kyoto normotensive (WKY) and hypertensive (SHR) rats
after chronic treatment of hydralazinea
I
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Abbreviations are the same as those used in Table 1.
Values are mean SEM.
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Fig. 2. Relationship between plasma phosphate concentration and
maximum tubular reabsorption of phosphate in WKY(O) and SHR (•).
tjon and its decreased excretion are manifestations of acute
changes in response to increased catecholamine secretion by
SHR. The circulating level of epinephrine is significantly higher
in completely immobilized SHR than in WKY [18]. It has been
demonstrated that increased endogenous epinephrine secretion
results in hypophosphatemia in humans [19]. Infusion of epi-
nephrine in dogs reduces renal phosphate excretion [20]. Our 3-
hr urine collections, however, were made in metabolic cages
without restriction of animals, yet the phosphate excretion was
lower in SHR. Plasma epinephrine concentration is not different
between unrestrained WKY and SHR [21].
The present study also disclosed that renal phosphate excre-
tion was not decreased in SHR after BP was reduced by chronic
hydralazine treatment. The inverse correlation of serum phos-
phate concentration and BP has been noted previously by other
investigators [10]. These findings suggest that hypertension is
responsible, directly or indirectly, for the abnormal phosphate
metabolism in SHR, although the causal relationship between
hypertension and abnormal phosphate metabolism is not clear.
Previous studies have shown that PTH is higher in human
hypertensive subjects [8], as well as in SHR [1, 4, 5]. Elevated
PTH levels are usually associated with low serum phosphate
concentrations and increased renal phosphate excretion. Our
finding of decreased renal phosphate clearance, however, is not
inconsistent with the elevation of PTH in SHR. Since renal
tubular reabsorption of phosphate is resistant to the PTH effect
when phosphate depletion exists [22], the animals used in the
present study were young and fast-growing rats. Phosphate
depletion as a result of chronic elevation of PTH in fast-growing
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Table 6. Effect of chronic hydralazine treatment on renal clearances of phosphate and sodium in 12-week-old male Wistar Kyoto normotensive
(WKY) and hypertensive (SHR) ratsa
Weight
g
MAP
mm Hg
GFR
mlIminIlOO g
P1
mg/dI
U1,V
xgImin
FE1
%
FENa
%
WKY
(N = 9)
SHR
(N = 9)
P value
226.3
234.8
NS
100.0
110.4
<0.02
0.68
0.61
NS
6.99
6.51
NS
23.0
28.7
NS
26.3
27.7
NS
0.06
0.45
<0.01
Abbreviations are the same as those used in Table 2.
a Values are mean SEM.
testinal active transport of phosphate absorption is calcium
dependent. Decreased calcium absorption suppresses phos-
phate absorption [26]. It is conceivable, therefore, that abnor-
mal calcium absorption in SHR may affect phosphate transport.
Whether elevated BP will affect gastrointestinal phosphate
secretion, or passive phosphate transport, thereby reducing net
phosphate absorption in SHR, is not clear.
Although several calcium metabolic perturbations at the
cellular level [27—29] have been reported in SHR, and detailed
by McCarron [301, it is difficult to delineate their involvement in
a precise mechanism for the etiology of abnormal phosphate
metabolism. Furthermore, how normalization of hypertension
or chronic hydralazine treatment per se ameliorates the de-
creased phosphate excretion in SHR remains uncertain. Fur-
ther studies with regard to PTH levels, intestinal calcium and
phosphate absorption and vitamin D metabolism in SHR with
chronic reduction of BP by antihypertensive agents are needed
to clarify this mechanism.
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